Menu
Back to Journals » ClinicoEconomics and Outcomes Research » Volume 3
Original Research
Indirect treatment comparison of bevacizumab + interferon-α-2a vs tyrosine kinase inhibitors in first-line metastatic renal cell carcinoma therapy
| Total article views | HTML views | PDF downloads | Totals | ||
|---|---|---|---|---|---|
| 17,333 | Dovepress* | 15,815+ | 3,479 | 19,294 | |
| PubMed Central* | 1,518 | 762 | 2,280 | ||
| Totals | 17,333 | 4,241 | 21,574 | ||
|
*Since 25 January 2011 +Since July 2016 |
|||||
| Total mentioned | Delicious | Others | |||
|---|---|---|---|---|---|
| 4 | 0 | 0 | 0 | 1 | 3 |
View citations on PubMed Central and Google Scholar